Go Back

Articles

1. Abdel-Wahab, M., A. Nitzsche-Bell, A. Olson, A. Polo, M.M. Shah, E. Zubizarreta, and S. Patel, Radiation Oncology in Global Health, in Radiology in global health : strategies, implementation, and applications, D.J. Mollura, M.P. Culp, and M.P. Lungren, Editors. 2019, Springer Science+Business Media: New York, NY. p. 349-360.

2. Coffey, M. and E. Rosenblatt, Guest short communication: Is education of RTTs really unnecessary? Technical Innovations & Patient Support in Radiation Oncology, 2018. 8: p. 1-2.

3. Coffey, M., E. Rosenblatt, G. Vandevelde, A. Osztavics, D. Pasini, P. Scherer, C. Dickie, V. Karadza, V. Van Egten, and M. Leech, A review of the Best Practice in Radiation Oncology project from 2008 to 2018. Technical Innovations & Patient Support in Radiation Oncology, 2018. 8: p. 3-7.

4. Ghosh, S., S. Baker, D.G. de Castro, L. Kepka, N. Kumar, V. Sinaika, J. Matiello, D. Lomidze, K. Dyttus-Cebulok, E. Rosenblatt, E. Fidarova, and W. Roa, Improved cost-effectiveness of short-course radiotherapy in elderly and/or frail patients with glioblastoma. Radiother Oncol, 2018. 127(1): p. 114-120, link.

5. Izewska, J., M. Coffey, P. Scalliet, E. Zubizarreta, T. Santos, I. Vouldis, and P. Dunscombe, Improving the quality of radiation oncology: 10years' experience of QUATRO audits in the IAEA Europe Region. Radiother Oncol, 2018. 126(2): p. 183-190, link.

6. Jacinto, A.A., E.S. Batalha Filho, L.S. Viana, P. De Marchi, R.C. Capuzzo, R.R. Gama, D. Boldrini Junior, C.R. Santos, G.D.J. Pinto, J.M. Dias, H.P. Canton, R. Carvalho, L.A. Radicchi, S. Bentzen, E. Zubizarreta, and A.L. Carvalho, Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma. BMC Cancer, 2018. 18(1): p. 1026, link.

7. Pistenmaa, D.A., M. Dosanjh, U. Amaldi, D. Jaffray, E. Zubizarreta, K. Holt, Y. Lievens, Y. Pipman, and C.N. Coleman, Changing the global radiation therapy paradigm. Radiother Oncol, 2018. 128(3): p. 393-399, link.

8. Rosenblatt, E., The known roots of a known problem. Gynecol Oncol Rep, 2018. 25: p. 109, link.

9. Rosenblatt, E., E. Fidarova, S. Ghosh, E. Zubizarreta, O. Unterkirhere, N. Semikoz, V. Sinaika, V. Kim, N. Karamyan, and I. Isayev, Quality of radiotherapy services in post-Soviet countries: An IAEA survey. Radiotherapy and Oncology, 2018, link.

11. Rosenblatt, E., R.R. Prasad, K. Hopkins, A. Polo, N. Ndlovu, M.S. Zaghloul, G. Paris, and L. Kochbati, Africa Radiation Oncology Network (AFRONET): an IAEA Telemedicine Pilot Project. 2018, 6.

12. Abdel-Wahab, M., E. Fidarova, and A. Polo, Global Access to Radiotherapy in Low- and Middle-income Countries. Clin Oncol (R Coll Radiol), 2017. 29(2): p. 99-104, link.

13. Abdel-Wahab, M., B. Lahoupe, A. Polo, E. Zubizarreta, R.R. Adnan, P. Johnston, A. Juric, F.E. Haffar, M. Andre, and A. Meghzifene, Assessment of cancer control capacity and readiness: the role of the International Atomic Energy Agency. Lancet Oncol, 2017. 18(10): p. e587-e594, link.

14. Abdel-Wahab, M., E. Zubizarreta, A. Polo, and A. Meghzifene, Improving Quality and Access to Radiation Therapy-An IAEA Perspective. Semin Radiat Oncol, 2017. 27(2): p. 109-117, link.

15. Barton, M.B., E. Zubizarreta, and M. Gospodarowicz, Radiotherapy in Low- and Middle-income Countries. What Can We Do Differently? Clin Oncol (R Coll Radiol), 2017. 29(2): p. 69-71, link.

16. Barton, M.B., E.H. Zubizarreta, and J.A. Polo Rubio, Radiotherapy in small countries. Cancer Epidemiol, 2017. 50(Pt B): p. 257-259, link.

17. Lievens, Y., M. Gospodarowicz, S. Grover, D. Jaffray, D. Rodin, J. Torode, M.L. Yap, E. Zubizarreta, G. Steering, and C. Advisory, Global impact of radiotherapy in oncology: Saving one million lives by 2035. Radiother Oncol, 2017. 125(2): p. 175-177, link.

18. Parkes, J., C. Hess, H. Burger, Y. Anacak, V. Ahern, S.C. Howard, M. Elhassan, S. Ahmed, M. Ghalibafian, A.N. Abbasi, B.M. Qureshi, M. Zaghloul, E. Zubizarreta, P. Bey, A. Davidson, E. Bouffet, and N. Esiashvili, Recommendations for the treatment of children with radiotherapy in low- and middle-income countries (LMIC): A position paper from the Pediatric Radiation Oncology Society (PROS-LMIC) and Pediatric Oncology in Developing Countries (PODC) working groups of the International Society of Pediatric Oncology (SIOP). Pediatr Blood Cancer, 2017. 64 Suppl 5(Suppl 5): p. S1-S11, link.

19. Rosenblatt, E., G.B. Prajogi, M. Barton, E. Fidarova, J.G. Eriksen, B. Haffty, B.A. Millar, A. Bustam, E. Zubizarreta, and M. Abdel-Wahab, Need for Competency-Based Radiation Oncology Education in Developing Countries. Creative Education, 2017. 08(01): p. 66-80, link.

21. Van Dyk, J., E. Zubizarreta, and Y. Lievens, Cost evaluation to optimise radiation therapy implementation in different income settings: A time-driven activity-based analysis. Radiother Oncol, 2017. 125(2): p. 178-185, link.

22. Zeegers, D., S. Venkatesan, S.W. Koh, G.K. Low, P. Srivastava, N. Sundaram, S. Sethu, B. Banerjee, M. Jayapal, O. Belyakov, R. Baskar, A.S. Balajee, and M.P. Hande, Biomarkers of Ionizing Radiation Exposure: A Multiparametric Approach. Genome Integr, 2017. 8(1): p. 6, link.

23. Zubizarreta, E., J. Van Dyk, and Y. Lievens, Analysis of Global Radiotherapy Needs and Costs by Geographic Region and Income Level. Clin Oncol (R Coll Radiol), 2017. 29(2): p. 84-92, link.

24. Hande, P., R. Sharan, and O. Belyakov, Strengthening Biological Dosimetry in Member States of the International Atomic Energy Agency. Genome Integr, 2016. 7(1): p. 1, link.

25. Lam, K.O., A.W. Lee, C.W. Choi, H.C. Sze, A.L. Zietman, K.I. Hopkins, and E. Rosenblatt, Global Pattern of Nasopharyngeal Cancer: Correlation of Outcome With Access to Radiation Therapy. Int J Radiat Oncol Biol Phys, 2016. 94(5): p. 1106-12, link.

26. Lam, K.O., A.W. Lee, W.T. Ng, and K.I. Hopkins, The International Atomic Energy Agency global initiatives on nasopharyngeal cancer treatment. Chin Clin Oncol, 2016. 5(2): p. 27, link.

27. Rosenblatt, E., A. Meghzifene, O. Belyakov, and M. Abdel-Wahab, Relevance of Particle Therapy to Developing Countries. Int J Radiat Oncol Biol Phys, 2016. 95(1): p. 25-9, link.

28. Socha, J., L. Kepka, S. Ghosh, W. Roa, N. Kumar, V. Sinaika, J. Matiello, D. Lomidze, D.G. de Castro, D. Hentati, and E. Fidarova, Outcome of treatment of recurrent glioblastoma multiforme in elderly and/or frail patients. J Neurooncol, 2016. 126(3): p. 493-8, link.

29. Yap, M.L., E. Zubizarreta, F. Bray, J. Ferlay, and M. Barton, Global Access to Radiotherapy Services: Have We Made Progress During the Past Decade? J Glob Oncol, 2016. 2(4): p. 207-215, link.

30. Atun, R., D.A. Jaffray, M.B. Barton, F. Bray, M. Baumann, B. Vikram, T.P. Hanna, F.M. Knaul, Y. Lievens, T.Y. Lui, M. Milosevic, B. O'Sullivan, D.L. Rodin, E. Rosenblatt, J. Van Dyk, M.L. Yap, E. Zubizarreta, and M. Gospodarowicz, Expanding global access to radiotherapy. Lancet Oncol, 2015. 16(10): p. 1153-86, link.

31. Hassan Metwally, M.A., R. Ali, M. Kuddu, T. Shouman, P. Strojan, K. Iqbal, R. Prasad, C. Grau, and J. Overgaard, IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma. Radiother Oncol, 2015. 116(1): p. 15-20, link.

32. Hoskin, P., A. Rojas, E. Fidarova, R. Jalali, A. Mena Merino, A. Poitevin, S. Oucrif, S. Abdelwahab, L. Kochbati, A. Plieskiene, F. Casas, S. Stojanovic, G. Schneider, and B. Jeremic, IAEA randomised trial of optimal single dose radiotherapy in the treatment of painful bone metastases. Radiother Oncol, 2015. 116(1): p. 10-4, link.

33. Jaffray, D.A., R. Atun, M. Barton, M. Baumann, M. Gospodarowicz, P. Hoskin, F.M. Knaul, Y. Lievens, E. Rosenblatt, J. Torode, J. Van Dyk, B. Vikram, and C. Union for International Cancer Control's Global Task Force on Radiotherapy for Cancer, Radiation therapy and the global health agenda. Clin Oncol (R Coll Radiol), 2015. 27(2): p. 67-9, link.

34. Jeremic, B., E. Fidarova, V. Sharma, M. Faheem, A.A. Ameira, C. Nasr Ben Ammar, A. Frobe, F. Lau, S. Brincat, and G. Jones, The International Atomic Energy Agency (IAEA) randomized trial of palliative treatment of incurable locally advanced non small cell lung cancer (NSCLC) using radiotherapy (RT) and chemotherapy (CHT) in limited resource setting. Radiother Oncol, 2015. 116(1): p. 21-6, link.

35. Konert, T., W. Vogel, M.P. MacManus, U. Nestle, J. Belderbos, V. Gregoire, D. Thorwarth, E. Fidarova, D. Paez, A. Chiti, and G.G. Hanna, PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014. Radiother Oncol, 2015. 116(1): p. 27-34, link.

36. Rosenblatt, E., O. Acuna, and M. Abdel-Wahab, The challenge of global radiation therapy: an IAEA perspective. Int J Radiat Oncol Biol Phys, 2015. 91(4): p. 687-9, link.

37. Rosenblatt, E., M. Barton, W. Mackillop, E. Fidarova, L. Cordero, J. Yarney, G. Lim, A. Abad, V. Cernea, S. Stojanovic-Rundic, P. Strojan, L. Kobachi, and A. Quarneti, Optimal radiotherapy utilisation rate in developing countries: An IAEA study. Radiother Oncol, 2015. 116(1): p. 35-7, link.

38. Rosenblatt, E., E. Zubizarreta, J. Izewska, S. Binia, F. Garcia-Yip, and P. Jimenez, Quality audits of radiotherapy centres in Latin America: a pilot experience of the International Atomic Energy Agency. Radiat Oncol, 2015. 10: p. 169, link.

39. Zubizarreta, E.H., E. Fidarova, B. Healy, and E. Rosenblatt, Need for radiotherapy in low and middle income countries - the silent crisis continues. Clin Oncol (R Coll Radiol), 2015. 27(2): p. 107-14, link.

40. Faulkner, C., A. Palmer, H. Williams, C. Wragg, H.R. Haynes, P. White, R.M. DeSouza, M. Williams, K. Hopkins, and K.M. Kurian, EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers. Br J Neurosurg, 2014. 29(1): p. 1-7, link.

41. Melidis, C., W.R. Bosch, J. Izewska, E. Fidarova, E. Zubizarreta, S. Ishikura, D. Followill, J. Galvin, Y. Xiao, M.A. Ebert, T. Kron, C.H. Clark, E.A. Miles, E.G. Aird, D.C. Weber, K. Ulin, D. Verellen, and C.W. Hurkmans, Radiation therapy quality assurance in clinical trials--Global Harmonisation Group. Radiother Oncol, 2014. 111(3): p. 327-9, link.

42. Melidis, C., W.R. Bosch, J. Izewska, E. Fidarova, E. Zubizarreta, K. Ulin, S. Ishikura, D. Followill, J. Galvin, A. Haworth, D. Besuijen, C.H. Clark, E. Miles, E. Aird, D.C. Weber, C.W. Hurkmans, and D. Verellen, Global harmonization of quality assurance naming conventions in radiation therapy clinical trials. Int J Radiat Oncol Biol Phys, 2014. 90(5): p. 1242-9, link.

43. Roberts, S.A., R. Miralbell, E.H. Zubizarreta, J.F. Fowler, and J.H. Hendry, A modelled comparison of prostate cancer control rates after high-dose-rate brachytherapy (3145 multicentre patients) combined with, or in contrast to, external-beam radiotherapy. Radiother Oncol, 2014. 111(1): p. 114-9, link.

44. Rosenblatt, E., Planning national radiotherapy services. Front Oncol, 2014. 4: p. 315, link.

45. Rosenblatt, E., M. Abdel-Wahab, M. El-Gantiry, I. Elattar, J.M. Bourque, M. Afiane, N. Benjaafar, S. Abubaker, Y. Chansilpa, B. Vikram, and P. Levendag, Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency. Radiat Oncol, 2014. 9: p. 67, link.

46. Weller, M., M. van den Bent, K. Hopkins, J.C. Tonn, R. Stupp, A. Falini, E. Cohen-Jonathan-Moyal, D. Frappaz, R. Henriksson, C. Balana, O. Chinot, Z. Ram, G. Reifenberger, R. Soffietti, W. Wick, and G. European Association for Neuro-Oncology Task Force on Malignant, EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol, 2014. 15(9): p. e395-403, link.

47. Abdel-Wahab, M., J.M. Bourque, Y. Pynda, J. Izewska, D. Van der Merwe, E. Zubizarreta, and E. Rosenblatt, Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis. Lancet Oncol, 2013. 14(4): p. e168-75, link.

48. Deatsch-Kratochvil, A.N., T.N. Pascual, A. Kesner, E. Rosenblatt, and R.K. Chhem, The International Atomic Energy Agency's activities in radiation medicine and cancer: promoting global health through diplomacy. Can Assoc Radiol J, 2013. 64(1): p. 2-5, link.

49. Goss, P.E., B.L. Lee, T. Badovinac-Crnjevic, K. Strasser-Weippl, Y. Chavarri-Guerra, J. St Louis, C. Villarreal-Garza, K. Unger-Saldana, M. Ferreyra, M. Debiasi, P.E. Liedke, D. Touya, G. Werutsky, M. Higgins, L. Fan, C. Vasconcelos, E. Cazap, C. Vallejos, A. Mohar, F. Knaul, H. Arreola, R. Batura, S. Luciani, R. Sullivan, D. Finkelstein, S. Simon, C. Barrios, R. Kightlinger, A. Gelrud, V. Bychkovsky, G. Lopes, S. Stefani, M. Blaya, F.H. Souza, F.S. Santos, A. Kaemmerer, E. de Azambuja, A.F. Zorilla, R. Murillo, J. Jeronimo, V. Tsu, A. Carvalho, C.F. Gil, C. Sternberg, A. Duenas-Gonzalez, D. Sgroi, M. Cuello, R. Fresco, R.M. Reis, G. Masera, R. Gabus, R. Ribeiro, R. Knust, G. Ismael, E. Rosenblatt, B. Roth, L. Villa, A.L. Solares, M.X. Leon, I. Torres-Vigil, A. Covarrubias-Gomez, A. Hernandez, M. Bertolino, G. Schwartsmann, S. Santillana, F. Esteva, L. Fein, M. Mano, H. Gomez, M. Hurlbert, A. Durstine, and G. Azenha, Planning cancer control in Latin America and the Caribbean. Lancet Oncol, 2013. 14(5): p. 391-436, link.

50. Hellebust, T.P., K. Tanderup, C. Lervag, E. Fidarova, D. Berger, E. Malinen, R. Potter, and P. Petric, Dosimetric impact of interobserver variability in MRI-based delineation for cervical cancer brachytherapy. Radiother Oncol, 2013. 107(1): p. 13-9, link.

51. Kadhim, M., S. Salomaa, E. Wright, G. Hildebrandt, O.V. Belyakov, K.M. Prise, and M.P. Little, Non-targeted effects of ionising radiation--implications for low dose risk. Mutat Res, 2013. 752(2): p. 84-98, link.

52. Levendag, P.C., F. Keskin-Cambay, C. de Pan, M. Idzes, M.A. Wildeman, I. Noever, I.K. Kolkman-Deurloo, A. Al-Mamgani, M. El-Gantiry, E. Rosenblatt, and D.N. Teguh, Local control in advanced cancer of the nasopharynx: is a boost dose by endocavitary brachytherapy of prognostic significance? Brachytherapy, 2013. 12(1): p. 84-9, link.

53. Myint, P., J. Wondergem, Y. Pynda, and G.O. Phillips, An international survey of tissue banking: a preliminary report. Cell Tissue Bank, 2013. 14(2): p. 159-65, link.

54. Petric, P., R. Hudej, P. Rogelj, M. Blas, K. Tanderup, E. Fidarova, C. Kirisits, D. Berger, J.C. Dimopoulos, R. Potter, and T.P. Hellebust, Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional study. Radiother Oncol, 2013. 107(1): p. 6-12, link.

55. Prasad, R.R. and P. Singh, Report of chronic myeloid leukemia from Indira Gandhi Institute of Medical Sciences, Regional Cancer Center, 2002-2009. Indian J Med Paediatr Oncol, 2013. 34(3): p. 172-4, link.

56. Ros, S. and R.K. Chhem, "Educating the educators" guidelines for education in radiation medicine: a pragmatic approach at International Atomic Energy Agency. Semin Nucl Med, 2013. 43(3): p. 202-7, link.

57. Rosenblatt, E., J. Izewska, Y. Anacak, Y. Pynda, P. Scalliet, M. Boniol, and P. Autier, Radiotherapy capacity in Europe--authors' reply. Lancet Oncol, 2013. 14(6): p. e198-9, link.

58. Rosenblatt, E., J. Izewska, Y. Anacak, Y. Pynda, P. Scalliet, M. Boniol, and P. Autier, Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database. Lancet Oncol, 2013. 14(2): p. e79-86, link.

59. Schmid, M.P., E. Fidarova, R. Potter, P. Petric, V. Bauer, V. Woehs, P. Georg, K. Kirchheiner, D. Berger, C. Kirisits, W. Dorr, and J.C. Dimopoulos, Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy. Acta Oncol, 2013. 52(7): p. 1384-90, link.

60. Schmid, M.P., B. Mansmann, M. Federico, J.C. Dimopoulous, P. Georg, E. Fidarova, W. Dorr, and R. Potter, Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients. A low-field MRI study. Strahlenther Onkol, 2013. 189(3): p. 238-44, link.

61. Wondergem, J., M. Boerma, K. Kodama, F.A. Stewart, and K.R. Trott, Cardiovascular effects after low-dose exposure and radiotherapy: what research is needed? Radiat Environ Biophys, 2013. 52(4): p. 425-34, link.

62. Dimopoulos, J.C., M.P. Schmid, E. Fidarova, D. Berger, C. Kirisits, and R. Potter, Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results. Int J Radiat Oncol Biol Phys, 2012. 82(5): p. 1880-8, link.

63. Kirchheiner, K., E. Fidarova, R.A. Nout, M.P. Schmid, A. Sturdza, E. Wiebe, A. Kranz, S. Polterauer, R. Potter, and W. Dorr, Radiation-induced morphological changes in the vagina. Strahlenther Onkol, 2012. 188(11): p. 1010-7, link.

64. Miralbell, R., S.A. Roberts, E. Zubizarreta, and J.H. Hendry, Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: alpha/beta = 1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys, 2012. 82(1): p. e17-24, link.

65. Rosenblatt, E., E. Zubizarreta, J. Wondergem, E. Fidarova, and J. Izewska, The International Atomic Energy Agency (IAEA): an active role in the global fight against cancer. Radiother Oncol, 2012. 104(3): p. 269-71, link.

66. Wondergem, J. and E. Rosenblatt, IAEA activities related to radiation biology and health effects of radiation. J Radiol Prot, 2012. 32(1): p. N123-7, link.

67. Yip, C.H., M. Samiei, E. Cazap, E. Rosenblatt, N.R. Datta, R. Camacho, D. Weller, S. Pannarunothai, C. Goh, F. Black, R. Kaur, M. Fitch, C. Sutcliffe, S. Sutcliffe, and I.-W. Group, Coordinating care and treatment for cancer patients. Asian Pac J Cancer Prev, 2012. 13(4 Suppl): p. 23-36, link.

68. Abdel-Wahab, M., E. Rosenblatt, O. Holmberg, and A. Meghzifene, Safety in radiation oncology: the role of international initiatives by the International Atomic Energy Agency. J Am Coll Radiol, 2011. 8(11): p. 789-94, link.

69. Salminen, E.K., K. Kiel, G.S. Ibbott, M.C. Joiner, E. Rosenblatt, E. Zubizarreta, J. Wondergem, and A. Meghzifene, International Conference on Advances in Radiation Oncology (ICARO): outcomes of an IAEA meeting. Radiat Oncol, 2011. 6: p. 11, link.

70. Jeremic, B., F. Casas, L. Wang, and B. Perin, Radiochemotherapy in extensive disease small cell lung cancer ED-SCLC. Front Radiat Ther Oncol, 2010. 42: p. 180-6, link.

71. Jeremic, B., F. Casas, L. Wang, and B. Perin, Radiation therapy for early stage (I/II) non-small cell lung cancer. Front Radiat Ther Oncol, 2010. 42: p. 87-93, link.

72. Overgaard, J., B.K. Mohanti, N. Begum, R. Ali, J.P. Agarwal, M. Kuddu, S. Bhasker, H. Tatsuzaki, and C. Grau, Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial. Lancet Oncol, 2010. 11(6): p. 553-60, link.

73. Rosenblatt, E., G. Jones, R.K. Sur, B. Donde, J.V. Salvajoli, S. Ghosh-Laskar, A. Frobe, A. Suleiman, Z. Xiao, and S. Nag, Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency. Radiother Oncol, 2010. 97(3): p. 488-94, link.

74. Sharma, V., P.M. Gaye, S.A. Wahab, N. Ndlovu, T. Ngoma, V. Vanderpuye, A. Sowuhami, D.A. Dawotola, J. Kigula-Mugambe, and B. Jeremic, Palliative radiation therapy practice for advanced esophageal carcinoma in Africa. Dis Esophagus, 2010. 23(3): p. 240-3, link.

75. Tian, Y., X.M. Li, J.J. Liu, Y.L. Ji, B. Wang, D. Yu, and Y.Q. Zhu, Comparison of radiotherapeutic management of operated breast cancer in 1999 and in 2006: a sampling survey on the southeast coast of China. Tumori, 2010. 96(2): p. 254-9, link.

76. Zimmermann, F., J. Wulf, I. Lax, Y. Nagata, R.D. Timmerman, I. Stojkovski, and B. Jeremic, Stereotactic body radiation therapy for early non-small cell lung cancer. Front Radiat Ther Oncol, 2010. 42: p. 94-114, link.

77. Aguirre Herrera, P. and J. Morales Pedraza, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Chile. Cell Tissue Bank, 2009. 10(2): p. 153-6, link.

78. Alvarez, I., J. Morales Pedraza, M.C. Saldias, H. Perez Campos, O. Wodowoz, M. Acosta, W. Vicentino, W. Silva, G. Rodriguez, D. Machin, and O. Alvarez, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Uruguay: development of tissues quality control and quality management system in the National Multi-Tissue Bank of Uruguay. Cell Tissue Bank, 2009. 10(2): p. 173-81, link.

79. Belderbos, J.S., L. Kepka, F.M. Kong, M.K. Martel, G.M. Videtic, and B. Jeremic, Elective nodal irradiation (ENI) in locally advanced non-small-cell lung cancer (NSCLC): evidence versus opinion? Int J Radiat Oncol Biol Phys, 2009. 74(1): p. 322; author reply 322-3, link.

80. Casas, F., L. Kepka, J.P. Agarwal, D. Dawotola, P. Gaye, S. Abdel-Wahab, L. Vashkevitch, T. Saghatelyan, B. Perin, and B. Jeremic, Radiochemotherapy in the elderly with lung cancer. Expert Rev Anticancer Ther, 2009. 9(10): p. 1405-11, link.

81. Frobe, A., G. Jones, B. Jaksic, T. Bokulic, M. Budanec, M. Iva, D. Stancic-Rokotov, D. Hrabar, A. Bolanca, E. Rosenblatt, and Z. Kusic, Intraluminal brachytherapy in the management of squamous carcinoma of the esophagus. Dis Esophagus, 2009. 22(6): p. 513-8, link.

82. Gamero, E.C. and J. Morales Pedraza, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Peru. Cell Tissue Bank, 2009. 10(2): p. 167-71, link.

83. Gay, H.A., C.H. Sibata, R.R. Allison, and B. Jeremic, Isodose-based methodology for minimizing the morbidity and mortality of thoracic hypofractionated radiotherapy. Radiother Oncol, 2009. 91(3): p. 369-78, link.

84. Hendry, J.H., S.L. Simon, A. Wojcik, M. Sohrabi, W. Burkart, E. Cardis, D. Laurier, M. Tirmarche, and I. Hayata, Human exposure to high natural background radiation: what can it teach us about radiation risks? J Radiol Prot, 2009. 29(2A): p. A29-42, link.

85. Herson, M.R., M.B. Mathor, and J. Morales Pedraza, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Brazil. Cell Tissue Bank, 2009. 10(2): p. 143-7, link.

86. Hilmy, N., M. Manjas, Ferdiansyah, B. Abbas, and J. Morales Pedraza, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Indonesia. Cell Tissue Bank, 2009. 10(2): p. 103-7, link.

87. Jeremic, B., Radiochemotherapy in lung cancer: from reality to reality. Expert Rev Anticancer Ther, 2009. 9(10): p. 1349-51, link.

88. Jeremic, B., Activities in the field of lung cancer coordinated by the section of applied radiation biology And Radiotherapy of the International Atomic Energy Agency. J Thorac Oncol, 2009. 4(8): p. 941-2, link.

89. Jeremic, B. and P. Hoskin, Radiochemotherapy in common solid tumours--from developed to a developing world. Clin Oncol (R Coll Radiol), 2009. 21(7): p. 513-4, link.

90. Jeremic, B. and B. Milicic, Pretreatment prognostic factors influencing distant metastasis-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Am J Clin Oncol, 2009. 32(5): p. 483-7, link.

91. Jeremic, B. and B. Milicic, Pretreatment prognostic factors of survival in patients with locally advanced nonmetastatic squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Am J Clin Oncol, 2009. 32(2): p. 163-8, link.

92. Kairiyama, E. and J. Morales Pedraza, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Argentina. Cell Tissue Bank, 2009. 10(2): p. 139-42, link.

93. Kang, Y.K., C.J. Yim, and J. Morales Pedraza, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Korea. Cell Tissue Bank, 2009. 10(2): p. 109-13, link.

94. Kepka, L., F. Casas, B. Perin, S. Abdel-Wahab, T. Saghatelyan, L. Vashkevitch, P.M. Gaye, D. Dawotola, J.P. Agarwal, and B. Jeremic, Radiochemotherapy for lung cancer in developing countries. Clin Oncol (R Coll Radiol), 2009. 21(7): p. 536-42, link.

95. Kepka, L., A. Sprawka, F. Casas, S. Abdel-Wahab, J.P. Agarwal, and B. Jeremic, Combination of radiotherapy and chemotherapy in locally advanced NSCLC. Expert Rev Anticancer Ther, 2009. 9(10): p. 1389-403, link.

96. Kepka, L., A. Sprawka, F. Casas, S. Abdel-Wahab, J.P. Agarwal, and B. Jeremic, Radiochemotherapy in small-cell lung cancer. Expert Rev Anticancer Ther, 2009. 9(10): p. 1379-87, link.

97. Lobo Gajiwala, A. and J. Morales Pedraza, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in India. Cell Tissue Bank, 2009. 10(2): p. 93-101, link.

98. MacManus, M., U. Nestle, K.E. Rosenzweig, I. Carrio, C. Messa, O. Belohlavek, M. Danna, T. Inoue, E. Deniaud-Alexandre, S. Schipani, N. Watanabe, M. Dondi, and B. Jeremic, Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. Radiother Oncol, 2009. 91(1): p. 85-94, link.

99. Martinez-Pardo, M.E., J. Morales Pedraza, and O. Sanchez Ramirez, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Mexico. Cell Tissue Bank, 2009. 10(2): p. 157-65, link.

100. Morales Pedraza, J., A future vision of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking for Asia and the Pacific and Latin American regions. Cell Tissue Bank, 2009. 10(2): p. 191-6, link.

101. Morales Pedraza, J. and G.O. Phillips, The evolution and impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Asia and the Pacific region. Cell Tissue Bank, 2009. 10(2): p. 87-91, link.

102. Morales Pedraza, J. and G.O. Phillips, The evolution and impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in the Latin American region. Cell Tissue Bank, 2009. 10(2): p. 133-7, link.

103. Morales Pedraza, J. and G.O. Phillips, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Asia and the Pacific and the Latin American regions. Cell Tissue Bank, 2009. 10(2): p. 79-86, link.

104. Morales Pedraza, J., E.O. Sanchez Noda, R.L. Rodriguez Cardona, and I. Otero, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Cuba. Cell Tissue Bank, 2009. 10(2): p. 149-52, link.

105. Nather, A. and J. Morales Pedraza, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Singapore. Cell Tissue Bank, 2009. 10(2): p. 119-24, link.

106. Nather, A., G.O. Phillips, J. Morales Pedraza, and C.C. Lee, Training tissue bank operators: the International Atomic Energy Agency (IAEA)/National University of Singapore (NUS) 10 years of experience. Cell Tissue Bank, 2009. 10(2): p. 183-90, link.

107. Roa, W., J.Z. Xing, C. Small, R. Kortmann, R. Miriamanoff, P. Okunieff, Y. Shibamoto, and B. Jeremic, Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme. Expert Rev Anticancer Ther, 2009. 9(11): p. 1643-50, link.

108. Salminen, E., Y. Anacak, S. Laskar, R.D. Kortmann, E. Raslawski, G. Stevens, and R.C. Ribeiro, Twinning partnerships through International Atomic Energy Agency (IAEA) to improve radiotherapy in common paediatric cancers in low- and mid-income countries. Radiother Oncol, 2009. 93(2): p. 368-71, link.

109. Vajaradul, Y. and J. Morales Pedraza, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Thailand. Cell Tissue Bank, 2009. 10(2): p. 125-32, link.

110. Yusof, N. and J. Morales Pedraza, The impact of the International Atomic Energy Agency (IAEA) program on radiation and tissue banking in Malaysia. Cell Tissue Bank, 2009. 10(2): p. 115-7, link.

111. Belderbos, J.S., L. Kepka, F.M. Spring Kong, M.K. Martel, G.M. Videtic, and B. Jeremic, Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-Cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys, 2008. 72(2): p. 335-42, link.

112. Hendry, J.H., M. Akahoshi, L.S. Wang, S.E. Lipshultz, F.A. Stewart, and K.R. Trott, Radiation-induced cardiovascular injury. Radiat Environ Biophys, 2008. 47(2): p. 189-93, link.

113. Jeremic, B. and C. Koning, Induction chemotherapy before chemoradiation in locally advanced non-small-cell lung cancer: failure after failure, again and again. J Clin Oncol, 2008. 26(10): p. e1-2, link.

114. Jeremic, B. and B. Milicic, Pretreatment prognostic factors of local recurrence-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Am J Clin Oncol, 2008. 31(3): p. 213-8, link.

115. Jeremic, B. and B. Milicic, Influence of low-dose daily cisplatin on the distant metastasis-free survival of patients with locally advanced nonmetastatic head and neck cancer treated with radiation therapy. Radiother Oncol, 2008. 87(2): p. 201-3, link.

116. Jeremic, B. and B. Milicic, From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer. Cancer, 2008. 112(4): p. 876-84, link.

117. Sharma, V., P.M. Gaye, S.A. Wahab, N. Ndlovu, T. Ngoma, V. Vanderpuye, A. Sowunmi, J. Kigula-Mugambe, and B. Jeremic, Patterns of practice of palliative radiotherapy in Africa, Part 1: Bone and brain metastases. Int J Radiat Oncol Biol Phys, 2008. 70(4): p. 1195-201, link.

118. Videtic, G.M., J.S. Belderbos, F.M. Spring Kong, L. Kepka, M.K. Martel, and B. Jeremic, Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: small-cell lung cancer (SCLC). Int J Radiat Oncol Biol Phys, 2008. 72(2): p. 327-34, link.

119. Wang, X., M.R. Allen, D.B. Burr, E.J. Lavernia, B. Jeremic, and D.P. Fyhrie, Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone. Bone, 2008. 43(4): p. 775-80, link.

120. Bese, N.S., J. Hendry, and B. Jeremic, Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys, 2007. 68(3): p. 654-61, link.

121. Davidson, S.E., A. Trotti, O.U. Ataman, J. Seong, F.N. Lau, N.W. da Motta, and B. Jeremic, Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys, 2007. 69(4): p. 1218-21, link.

122. Jeremic, B., Low incidence of isolated nodal failures after involved-field radiation therapy for non small-cell lung cancer: blinded by the light? J Clin Oncol, 2007. 25(35): p. 5543-5, link.

123. Jeremic, B. and B. Milicic, Influence of interfraction interval on local tumor control in patients with limited-disease small-cell lung cancer treated with radiochemotherapy. Int J Radiat Oncol Biol Phys, 2007. 68(2): p. 426-32, link.

124. Jeremic, B. and S. Pitz, Primary optic nerve sheath meningioma: stereotactic fractionated radiation therapy as an emerging treatment of choice. Cancer, 2007. 110(4): p. 714-22, link.

125. Kepka, L., V. Danilova, T. Saghatelyan, A. Bajcsay, O. Utehina, S. Stojanovic, D. Yalman, A. Demiral, O. Bondaruk, M. Kuddu, B. Jeremic, and A. International Atomic Energy, Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: results of an International Atomic Energy Agency (IAEA) survey. Lung Cancer, 2007. 56(2): p. 235-45, link.

126. Macbeth, F.R., R.P. Abratt, K.H. Cho, R.J. Stephens, B. Jeremic, and A. International Atomic Energy, Lung cancer management in limited resource settings: guidelines for appropriate good care. Radiother Oncol, 2007. 82(2): p. 123-31, link.

127. Stojkovski, I., M. Dondi, B. Jeremic, and P. Andreo, The role of IAEA in preparation of recommendations for the use of PET/CT in radiotherapy planning. Biomed Imaging Interv J, 2007. 3(1): p. e19, link.

128. Agarawal, J.P., T. Swangsilpa, Y. van der Linden, D. Rades, B. Jeremic, and P.J. Hoskin, The role of external beam radiotherapy in the management of bone metastases. Clin Oncol (R Coll Radiol), 2006. 18(10): p. 747-60, link.

129. Auperin, A., C. Le Pechoux, J.P. Pignon, C. Koning, B. Jeremic, G. Clamon, L. Einhorn, D. Ball, M.G. Trovo, H.J. Groen, J.A. Bonner, T. Le Chevalier, R. Arriagada, and G. Meta-Analysis of Cisplatin/carboplatin based Concomitant Chemotherapy in non-small cell Lung Cancer, Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients. Ann Oncol, 2006. 17(3): p. 473-83, link.

130. Bese, N.S., K. Kiel, K. El-Gueddari Bel, O.B. Campbell, B. Awuah, B. Vikram, and A. International Atomic Energy, Radiotherapy for breast cancer in countries with limited resources: program implementation and evidence-based recommendations. Breast J, 2006. 12 Suppl 1(Suppl 1): p. S96-102, link.

131. Chen, Y., A. Trotti, C.N. Coleman, M. Machtay, R.O. Mirimanoff, J. Hay, C. O'Brien P, B. El-Gueddari, J.V. Salvajoli, and B. Jeremic, Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation. Int J Radiat Oncol Biol Phys, 2006. 64(5): p. 1442-51, link.

132. Coffey, M., P. Engel-Hills, M. El-Gantiry, N. Benjaafar, K. Wilkinson, and B. Vikram, A core curriculum for RTTs (radiation therapists/radiotherapy radiographers) designed for developing countries under the auspices of the international atomic energy agency (IAEA). Radiother Oncol, 2006. 81(3): p. 324-5, link.

133. Eniu, A., R.W. Carlson, Z. Aziz, J. Bines, G.N. Hortobagyi, N.S. Bese, R.R. Love, B. Vikram, A. Kurkure, B.O. Anderson, T. Global Summit, and P. Allocation of Resources, Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J, 2006. 12 Suppl 1: p. S38-53, link.

134. Hendry, J.H., B. Jeremic, and E.H. Zubizarreta, Normal tissue complications after radiation therapy. Rev Panam Salud Publica, 2006. 20(2-3): p. 151-60, link.

135. Horsman, M.R., L. Bohm, G.P. Margison, L. Milas, J.F. Rosier, G. Safrany, E. Selzer, M. Verheij, and J.H. Hendry, Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting. Int J Radiat Oncol Biol Phys, 2006. 64(2): p. 551-61, link.

136. Jeremic, B., Timing of concurrent radiotherapy and chemotherapy in limited-disease small-cell lung cancer: "Meta-analysis of meta-analyses". Int J Radiat Oncol Biol Phys, 2006. 64(4): p. 981-2, link.

137. Jeremic, B., B. Milicic, A. Dagovic, L. Acimovic, and S. Milisavljevic, Pretreatment prognostic factors in patients with early-stage (I/II) non-small-cell lung cancer treated with hyperfractionated radiation therapy alone. Int J Radiat Oncol Biol Phys, 2006. 65(4): p. 1112-9, link.

138. San Jose, S., M.D. Arnaiz, A. Lucas, V. Navarro, G. Serrano, M. Zaderazjko, B. Jeremic, and F. Guedea, Radiation therapy alone in elderly with early stage non-small cell lung cancer. Lung Cancer, 2006. 52(2): p. 149-54, link.

139. Wambersie, A., J.H. Hendry, P. Andreo, P.M. DeLuca, R. Gahbauer, H. Menzel, and G. Whitmore, The RBE issues in ion-beam therapy: conclusions of a joint IAEA/ICRU working group regarding quantities and units. Radiat Prot Dosimetry, 2006. 122(1-4): p. 463-70, link.

140. Dobrowsky, W., N.G. Huigol, R.S. Jayatilake, N.I. Kizilbash, S. Okkan, T.V. Kagiya, and H. Tatsuzaki, AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cancer cervix: initial results of an IAEA multicentre randomized trial. J Cancer Res Ther, 2005. 1(2): p. 75-8, link.

141. Maddineni, S.B., V.K. Sangar, J.H. Hendry, G.P. Margison, and N.W. Clarke, Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines. Br J Cancer, 2005. 92(1): p. 125-30, link.

142. Parashar, B., S. Latha Shankar, K. O'Guin, J. Butler, B. Vikram, and B. Shafit-Zagardo, Inhibition of human neuroblastoma cell growth by CAY10404, a highly selective Cox-2 inhibitor. J Neurooncol, 2005. 71(2): p. 141-8, link.

143. Vasanthan, A., M. Mitsumori, J.H. Park, Z. Zhi-Fan, Z. Yu-Bin, P. Oliynychenko, H. Tatsuzaki, Y. Tanaka, and M. Hiraoka, Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys, 2005. 61(1): p. 145-53, link.

144. West, C.M., M.J. McKay, T. Holscher, M. Baumann, I.J. Stratford, R.G. Bristow, M. Iwakawa, T. Imai, S.M. Zingde, M.S. Anscher, J. Bourhis, A.C. Begg, K. Haustermans, S.M. Bentzen, and J.H. Hendry, Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting. Int J Radiat Oncol Biol Phys, 2005. 62(5): p. 1264-73, link.

145. Kim, J.Y., C.H. Kim, I.J. Stratford, A.V. Patterson, and J.H. Hendry, The bioreductive agent RH1 and gamma-irradiation both cause G2/M cell cycle phase arrest and polyploidy in a p53-mutated human breast cancer cell line. Int J Radiat Oncol Biol Phys, 2004. 58(2): p. 376-85, link.

146. Kim, J.Y., A.V. Patterson, I.J. Stratford, and J.H. Hendry, The importance of DT-diaphorase and hypoxia in the cytotoxicity of RH1 in human breast and non-small cell lung cancer cell lines. Anticancer Drugs, 2004. 15(1): p. 71-7, link.

147. Kim, J.Y., C.M. West, H. Valentine, T.H. Ward, A.V. Patterson, I.J. Stratford, S.A. Roberts, and J.H. Hendry, Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiation. Radiother Oncol, 2004. 70(3): p. 311-7, link.

148. Roberts, S.A., J.H. Hendry, R. Swindell, J.M. Wilkinson, and R.D. Hunter, Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: a radiobiological analysis of a randomised clinical trial. Radiother Oncol, 2004. 70(1): p. 63-74, link.

149. Sangar, V.K., R. Cowan, G.P. Margison, J.H. Hendry, and N.W. Clarke, An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines. Br J Cancer, 2004. 90(2): p. 542-8, link.

150. Sindermann, J.R., V. Verin, J.W. Hopewell, H.P. Rodemann, and J.H. Hendry, Biological aspects of radiation and drug-eluting stents for the prevention of restenosis. Cardiovasc Res, 2004. 63(1): p. 22-30, link.

151. Sur, R., B. Donde, C. Falkson, S.N. Ahmed, V. Levin, S. Nag, R. Wong, and G. Jones, Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. Brachytherapy, 2004. 3(4): p. 191-5, link.

152. Van Der Giessen, P.H., J. Alert, C. Badri, M. Bistrovic, D. Deshpande, D. Kardamakis, D. Van Der Merwe, N. Da Motta, L. Pinillos, R. Sajjad, Y. Tian, and V. Levin, Multinational assessment of some operational costs of teletherapy. Radiother Oncol, 2004. 71(3): p. 347-55, link.

153. Vikram, B., The PSA conundrum. Radiother Oncol, 2004. 71(1): p. 1-2, link.

154. Wambersie, A., J. Hendry, J. Gueulette, R. Gahbauer, R. Potter, and V. Gregoire, Radiobiological rationale and patient selection for high-LET radiation in cancer therapy. Radiother Oncol, 2004. 73 Suppl 2: p. S1-14, link.

155. Zubizarreta, E.H., A. Poitevin, and C.V. Levin, Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA). Radiother Oncol, 2004. 73(1): p. 97-100, link.

156. Grau, C., J. Prakash Agarwal, K. Jabeen, A. Rab Khan, S. Abeyakoon, T. Hadjieva, I. Wahid, S. Turkan, H. Tatsuzaki, K.A. Dinshaw, and J. Overgaard, Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial. Radiother Oncol, 2003. 67(1): p. 17-26, link.

157. Vikram, B., Cancers of the head and neck region in developing countries. Radiother Oncol, 2003. 67(1): p. 1-2, link.

158. Huilgol, N.G., W. Dobrowsky, H. Tatsuzaki, N.A. Chatterjee, V.T. Kagiya, and K. Das, Sanazole as a sensitizer of hypoxic cells with radical radiation in the treatment of advanced cancer of cervix an Indian experience. Indian J Cancer, 2002. 39(2): p. 39-44, link.

159. Levin, V. and H. Tatsuzaki, Radiotherapy services in countries in transition: gross national income per capita as a significant factor. Radiother Oncol, 2002. 63(2): p. 147-50, link.

160. Nag, S., M. Dally, M. de la Torre, H. Tatsuzaki, N. Kizilbash, S. Kurusun, L. Pinillos, B. Pokrajac, R. Sur, and V. Levin, Recommendations for implementation of high dose rate 192Ir brachytherapy in developing countries by the Advisory Group of International Atomic Energy Agency. Radiother Oncol, 2002. 64(3): p. 297-308, link.

161. Sur, R.K., C.V. Levin, B. Donde, V. Sharma, L. Miszczyk, and S. Nag, Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys, 2002. 53(1): p. 127-33, link.

162. Ohara, K., H. Tatsuzaki, N.G. Molotkova, T. Oda, K. Yuzawa, Y. Saida, Y. Matsuzaki, W. Shimizu, T. Todoroki, K. Fukao, N. Tanaka, and Y. Itai, Utility of serum CA 19-9 monitoring in preoperative radiotherapy for pancreatic cancer. Hepatogastroenterology, 2001. 48(39): p. 859-63, link.

163. Ohara, K., H. Tatsuzaki, W. Shimizu, S. Sugahara, N.G. Molotkova, and Y. Itai, Exfoliative tumor clearance following radiotherapy estimated by comparing radioresponse between primary esophageal cancer and its lymph node metastasis. Hepatogastroenterology, 2001. 48(42): p. 1648-51, link.

164. Salazar, O.M., T. Sandhu, N.W. da Motta, M.A. Escutia, E. Lanzos-Gonzales, A. Mouelle-Sone, A. Moscol, M. Zaharia, and S. Zaman, Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA). Int J Radiat Oncol Biol Phys, 2001. 50(3): p. 765-75, link.

165. Tatsuzaki, H. and C.V. Levin, Quantitative status of resources for radiation therapy in Asia and Pacific region. Radiother Oncol, 2001. 60(1): p. 81-9, link.

166. Vatnitsky, S., P. Ortiz Lopez, J. Izewska, A. Meghzifene, and V. Levin, The radiation overexposure of radiotherapy patients in Panama 15 June 2001. Radiother Oncol, 2001. 60(3): p. 237-8, link.

167. Levin, C.V., B. El Gueddari, and A. Meghzifene, Radiation therapy in Africa: distribution and equipment. Radiother Oncol, 1999. 52(1): p. 79-84, link.